Tilo had been born with a genetic disorder that had impeded his growth, resigning him to dwarfism. This condition is the ...

An actor with a rare genetic condition is captivating audiences with a "dazzling" performance in a televised period drama ...

Jason Zemansky, an analyst from Bank of America Securities, maintained the Buy rating on BridgeBio Pharma (BBIO – Research Report). The ...

Developmental milestones help us understand when a child needs help, but meeting them early doesn’t necessarily predict ...

Each of the individual types of dwarfism is even rarer. Achondroplasia makes up 70% of all cases of dwarfism. It affects about one of every 25,000 to 30,000 newborns. With achondroplasia, there is a ...

SAR-442501 is under clinical development by Sanofi and currently in Phase I for Achondroplasia. According to GlobalData, Phase I drugs for Achondroplasia does not have sufficient historical data to ...

Infigratinib phosphate is under clinical development by QED Therapeutics and currently in Phase III for Achondroplasia. According to GlobalData, Phase III drugs for Achondroplasia does not have ...